“The EFSA review is considered definitive and it found that there was no need for a risk assessment of the safety of A1 milk,” said Wilkinson. “It concluded there was no established link between A1 milk and non-communicable diseases such as autism and type 1 diabetes, based on the science available. Flying in international experts to discuss a report that reached such clear conclusions would not add to what we already know.”
The expert panel would have cost about NZ$60,000 to convene.
The minister said the decision wasn’t intended to discourage anyone interested in doing further research in this area of their own accord. Researchers are able to put forward proposals for funding to the Health Research Council of New Zealand, the Crown agency responsible for public good health research.
The most common proteins in cow’s milk are beta-casein A1 and beta-casein A2. Milk high in beta-casein A1 is referred to as ‘A1 milk’, while milk high in beta-casein A2 is referred to as ‘A2 milk’.
Source: New Zealand government
© FoodBev Media Ltd 2024